Our Divisions at a Glance
As a leading international partner of biopharmaceutical research and the industry, Sartorius supports its customers in the development and manufacture of biotech medications and vaccines. Our goal is to make complex and expensive development of biopharmaceuticals and their production safer and more efficient. We cover the entire value-added chain of the biopharmaceutical industry and help with our products and services to ensure that novel therapies reach the market faster and are accessible to more people worldwide. Sartorius employs over 9,000 people across the globe and has Group companies in more than 30 countries.
Bioprocess Solutions
In the Bioprocess Solutions Division, Sartorius offers a broad product portfolio that covers all steps in the production of a biopharmaceutical. The company has held leading market positions for years in its core technologies, such as filtration, fermentation, cell cultivation and single-use bags and containers.
Key Figures
| € in millions | 2019 | 2018 | Δ in % |
| Sales revenue | 1,372.1 | 1,143.1 | 18.11) |
| Order intake | 1,479.3 | 1,233.7 | 18.01) |
| Underlying EBITDA | 406.8 | 326.9 | 24.5 |
As a % of sales | 29.6 | 28.6 | |
| Employees as of Dec. 31 | 6,106 | 5,498 | 11.1 |
1) In constant currencies
Lab Products & Services
The Lab Products & Services Division offers laboratories in the pharmaceutical and biopharmaceutical industries as well as at academic research institutes innovative solutions for bioanalytics, in addition to premium laboratory products, consumables and services. Sartorius is among the market leaders in laboratory balances, pipettes and lab consumables.
Key Figures
| € in millions | 2019 | 2018 | Δ in % |
| Sales revenue | 454.9 | 423.0 | 5.91) |
| Order intake | 460.3 | 428.8 | 5.71) |
| Underlying EBITDA | 89.0 | 78.1 | 14.0 |
As a % of sales | 19.6 | 18.5 | |
| Employees as of Dec. 31 | 2,910 | 2,627 | 10.8 |
1) In constant currencies